A detailed history of Armistice Capital, LLC transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,032,000 shares of SLGL stock, worth $1.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,032,000
Previous 2,078,000 2.21%
Holding current value
$1.32 Million
Previous $2.04 Million 11.2%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.66 - $1.05 $30,360 - $48,300
-46,000 Reduced 2.21%
2,032,000 $1.81 Million
Q1 2024

May 15, 2024

SELL
$0.95 - $1.5 $54,150 - $85,500
-57,000 Reduced 2.67%
2,078,000 $2.04 Million
Q3 2023

Nov 14, 2023

SELL
$1.63 - $3.94 $118,989 - $287,620
-73,000 Reduced 3.31%
2,135,000 $3.48 Million
Q2 2023

Aug 14, 2023

SELL
$2.99 - $4.15 $598,000 - $830,000
-200,000 Reduced 8.31%
2,208,000 $6.6 Million
Q1 2023

May 15, 2023

BUY
$3.44 - $5.32 $8.28 Million - $12.8 Million
2,408,000 New
2,408,000 $9.34 Million

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $15M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.